Trackable Growth Market leadership in infusion therapy and vascular access, with ongoing product expansion such as precision IV pumps and an expanded IV Performance Platform, signaling ongoing buying interest in advanced IV hardware and software.

Regulatory Momentum FDA clearances for new pump categories and recalls related to labeling indicate a dynamic regulatory environment; opportunities exist to position reliability, safety enhancements, and compliant devices to mitigate recall risk for healthcare providers.

Strategic Partnerships Recent collaborations, including the MyAcapella OPEP app launch with VisionHealth and AVATAR research funding, suggest a receptiveness to integrated solutions and telehealth/remote patient management opportunities.

Financial Opportunities Revenue scale and investor activity imply interest from facilities and systems in upgrading infusion and respiratory therapy portfolios; target mid-to-large hospitals and outpatient networks for procurement of next‑gen pumps and closed-system devices.

Risk-Aware Selling Notable product recalls and safety-labeling incidents create a demand for enhanced service, training, and compliance packages; offer expanded service contracts, training programs, and device verification services to reduce risk for purchasers.